Abstract:Microsatellite instability (MSI) is an important genomic biomarker for cancer diagnosis and treatment, and sequencing-based approaches are often applied to identify MSI because of its fastness and efficiency. These approaches, however, may fail to identify MSI on one or more sub-clones for certain cancers with a high degree of heterogeneity, leading to erroneous diagnoses and unsuitable treatments. Besides, the computational cost of identifying sub-clonal MSI can be exponentially increased when multiple sub-clones with different length distributions share MSI status. Herein, this paper proposes "scMSI", an accurate and efficient estimation of sub-clonal MSI to identify the microsatellite status. scMSI is an integrative Bayesian method to deconvolute the mixed-length distribution of sub-clones by a novel alternating iterative optimization procedure based on a subtle generative model. During the process of deconvolution, the optimized division of each sub-clone is attained by a heuristic algorithm, aligning with clone proportions that adhere optimally to the sample's clonal structure. To evaluate the performance, 16 patients diagnosed with endometrial cancer, exhibiting positive responses to the treatment despite having negative MSI status based on sequencing-based approaches, were considered. Excitingly, scMSI reported MSI on sub-clones successfully, and the findings matched the conclusions on immunohistochemistry. In addition, testing results on a series of experiments with simulation datasets concerning a variety of impact factors demonstrated the effectiveness and superiority of scMSI in detecting MSI on sub-clones over existing approaches. scMSI provides a new way of detecting MSI for cancers with a high degree of heterogeneity. Microsatellites are short, repetitive sequences of DNA, and their instability (MSI) is an important marker for cancer diagnosis and treatment. However, tumors often consist of diverse groups of cells, or sub-clones, and existing sequencing methods often fail to detect MSI that occurs only in some sub-clones. This can lead to incorrect diagnoses and prevent patients from receiving the most effective therapies. To solve this problem, we developed a new computational method named as scMSI to accurately identify MSI of sub-clones within a tumor. scMSI utilizes advanced statistical techniques to deconvolute the complex mixture of genetic mutations. As a result, we can use scMSI to detect sub-clonal MSI that other methods might miss. In the testing, we examined scMSI on samples from 16 patients with endometrial cancer, who had been incorrectly labeled as MSI-negative by existing methods. Our method successfully identified MSI in sub-clones, showing that scMSI outperforms existing tools. Additionally, simulation experiments under various conditions further confirmed the effectiveness of scMSI in detecting sub-clonal MSI. By improving the detection of MSI in cancers with a high degree of heterogeneity, scMSI can enhance cancer diagnosis and treatments more effectively.

MSIsensor-RNA: Microsatellite Instability Detection for Bulk and Single-cell Gene Expression Data

MSIsensor-pro: Fast, Accurate, and Matched-normal-sample-free Detection of Microsatellite Instability.

MSIsensor-ct: microsatellite instability detection using cfDNA sequencing data

MSIsensor: microsatellite instability detection using paired tumor-normal sequence data.

MSIsensor: microsatellite instability detection using paired tumor-normal sequence data

Detecting microsatellite instability by length comparison of microsatellites in the 3′ untranslated region with RNA-seq

MSI-XGNN: an explainable GNN computational framework integrating transcription- and methylation-level biomarkers for microsatellite instability detection

A Method for Improving the Detection Accura-cy of MSIsensor Based on Downsampling

A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing.

Detection of Microsatellite Instability from Circulating Tumor DNA by Targeted Deep Sequencing.

A Novel Method for Microsatellite Instability Detection by Liquid Biopsy Based on Next-generation Sequencing

scMSI: Accurately inferring the sub-clonal Micro-Satellite status by an integrated deconvolution model on length spectrum

Scmsi: Accurately Detect the Sub-Clonal Micro-Satellite Instability by an Integrative Bayesian Model

Accurate Pan-Cancer Molecular Diagnosis of Microsatellite Instability by Single-Molecule Molecular Inversion Probe Capture and High-Throughput Sequencing

Evaluating the Microsatellite Instability of Colorectal Cancer Based on Multimodal Deep Learning Integrating Histopathological and Molecular Data

Microsatellite Instability Detection from Plasma of Colorectal Cancer Patients.

Monitoring Microsatellite Instability (MSI) in Circulating Tumor DNA by Next-Generation DNA-seq.

A Robust Microsatellite Instability Detection Model for Unpaired Colorectal Cancer Tissue Samples

A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study

DeltaMSI: artificial intelligence-based modeling of microsatellite instability scoring on next-generation sequencing data

Abstract 2943: Investigation of microsatellite instability in RNA compared to DNA, using microsatellite targeted, anchored multiplex PCR and NGS